Elevance Health, Inc. closed its sale of $500 million aggregate principal amount of its 4.900% Notes due 2026, $1,000 million aggregate principal amount of its 4.750% Notes due 2033, and $1,100 million aggregate principal amount of its 5.125% Notes due 2053.